#United States #Charlotte, North Carolina #regenerative medicine #QC Kinetix #Mark Montini

QC Kinetix Strengthens Leadership Team for Future Growth

QC Kinetix, a leader in regenerative medicine in North America, has embarked on a significant brand transformation aimed at improving patient care and operational efficiency. The company recently announced the promotion of four key members within its leadership team, a move designed to enhance its capabilities in delivering advanced treatment solutions for those suffering from pain.

New Promotions

CEO Mark Montini, known for his dynamic and innovative approach since his appointment last year, emphasized the importance of these promotions in driving QC Kinetix’s vision forward. The newly promoted leaders are:

• - Alexandra White, PA-C - Promoted to Vice President of Medical Operations, Alexandra began her journey with QC Kinetix as a Senior Medical Project Manager. In her new role, she will oversee the delivery of exceptional patient experiences and uphold the company’s high standards in alternative treatment options.

• - Dr. Corey Riser, DC, CFMP - Formerly the National Director of Sales, Dr. Riser steps into the role of Vice President of Growth. His extensive experience in functional medicine sets a strong foundation for expanding QC Kinetix’s reach and influence in the regenerative medicine market.

• - Ginger Arntz, MSN, FNP-C - After serving as Director of Business Development, Ginger has been promoted to Vice President of Innovation. She will spearhead initiatives to integrate cutting-edge advancements into the company’s practices, ultimately focusing on improving patient outcomes and operational success.

• - Michael Huzl - Transitioning from Director of Finance to Vice President of Finance, Michael brings nearly two decades of experience to ensure the financial health and efficiency of QC Kinetix as it scales up operations.

A Transformation Journey

Under Montini's leadership, QC Kinetix is enhancing its business model to prioritize both patient care and franchisee support. The organization is committed to responsible franchising, which emphasizes sustainable growth and long-term success for its franchise partners. Over the next 18 months, QC Kinetix plans to implement several key advancements that will focus on refining operations, introducing innovative solutions, and maintaining a strong patient outcome-oriented philosophy.

The transformation strategy is built on a three-phase approach—revive, reset, and reload—aimed at aligning the franchise system with shared values and a vision for responsible expansion. As Montini noted, the contributions of the newly promoted leaders are essential to the company’s ongoing success.

MS Montini stated, “These four promotions are a key strategic decision in our current brand transformation, and as we continue to scale and innovate. QC Kinetix is devoted to raising the bar in patient care.” This commitment extends beyond immediate business goals; it integrates a holistic approach to franchising that ensures franchisees are positioned for success in a growing market.

The Future of Regenerative Medicine

The founders of QC Kinetix understand the potential of regenerative medicine to provide effective treatment for a wide range of health issues. The regenerative medicine sector itself is witnessing remarkable growth, with projections indicating that the North American market will expand at a CAGR of over 20%—reaching $16.5 billion by 2026, up from $6.48 billion in 2021. This growth trajectory underscores the importance of QC Kinetix's transformational strategies and the commitment to innovative patient care.

Incorporating the body's regenerative capabilities, QC Kinetix is pioneering a shift away from invasive surgeries and addictive pain medications. Its innovative treatments leverage natural biologic methods to enhance recovery and improve quality of life for patients, with a team of experts that includes board-certified medical personnel across various specialties.

Currently, QC Kinetix operates 145 locations across more than 50 cities, with ambitious plans to open an additional 350 sites nationwide in the coming years. This operational model has not only established QC Kinetix as a dominant force in the regenerative medicine landscape but also positioned it as one of the fastest-growing franchises in North America.

To learn more about QC Kinetix and its groundbreaking approach to regenerative medicine, visit their official website at qckinetix.com.